Cargando…

Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant

Detalles Bibliográficos
Autores principales:	Chemaitelly, Hiam, Bertollini, Roberto, Abu-Raddad, Laith J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8693689/ https://www.ncbi.nlm.nih.gov/pubmed/34910864 http://dx.doi.org/10.1056/NEJMc2110300

Ejemplares similares

Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Duration of immune protection of SARS-CoV-2 natural infection against reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Protection against Reinfection with the Omicron BA.2.75 Subvariant
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

The elusive goal of COVID-19 vaccine immunity
por: Abu-Raddad, Laith J, et al.
Publicado: (2023)

1882. Effects of BA.1/BA.2 Subvariant, Vaccination, and Prior Infection on Infectiousness of SARS-CoV-2 Omicron Infections
por: Qassim, Suelen, et al.
Publicado: (2022)

External infections contribute minimally to HIV incidence among HIV sero-discordant couples in sub-Saharan Africa
por: Chemaitelly, Hiam, et al.
Publicado: (2013)

Waning effectiveness of COVID-19 vaccines
por: Chemaitelly, Hiam, et al.
Publicado: (2022)

Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Modeling the population-level impact of treatment on COVID-19 disease and SARS-CoV-2 transmission
por: Makhoul, Monia, et al.
Publicado: (2022)

2332. COVID-19 Primary Series and Booster Vaccination and Potential for Immune Imprinting
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
por: Abu-Raddad, Laith J., et al.
Publicado: (2021)

Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide
por: Ayoub, Houssein H., et al.
Publicado: (2020)

Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
por: Abu-Raddad, Laith J., et al.
Publicado: (2022)

Dynamics of non-cohabiting sex partnering in sub-Saharan Africa: a modelling study with implications for HIV transmission
por: Omori, Ryosuke, et al.
Publicado: (2015)

The Epidemiology of Hepatitis C Virus in the Fertile Crescent: Systematic Review and Meta-Analysis
por: Chemaitelly, Hiam, et al.
Publicado: (2015)

Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
por: Ayoub, Houssein H., et al.
Publicado: (2021)

2288. Short and Longer-Term All-Cause Mortality among SARS CoV-2-Infected Persons and the Pull-Forward Phenomenon in Qatar
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Analyzing inherent biases in SARS-CoV-2 PCR and serological epidemiologic metrics
por: Makhoul, Monia, et al.
Publicado: (2022)

BNT162b2 antigen dose and SARS-CoV-2 omicron infection in adolescents
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
por: Tayar, Elias, et al.
Publicado: (2023)

Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions
por: Kouyoumjian, Silva P., et al.
Publicado: (2018)

Temporal evolution of HIV sero-discordancy patterns among stable couples in sub-Saharan Africa
por: Awad, Susanne F., et al.
Publicado: (2018)

Characterizing the transitioning epidemiology of herpes simplex virus type 1 in the USA: model-based predictions
por: Ayoub, Houssein H., et al.
Publicado: (2019)

Epidemiological Impact of Novel Preventive and Therapeutic HSV-2 Vaccination in the United States: Mathematical Modeling Analyses
por: Ayoub, Houssein H., et al.
Publicado: (2020)

HSV-2 as a biomarker of HIV epidemic potential in female sex workers: meta-analysis, global epidemiology and implications
por: Chemaitelly, Hiam, et al.
Publicado: (2020)

Epidemiological Impact of SARS-CoV-2 Vaccination: Mathematical Modeling Analyses
por: Makhoul, Monia, et al.
Publicado: (2020)

Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
por: Abu-Raddad, Laith J, et al.
Publicado: (2020)

Does infection with Chlamydia trachomatis induce long-lasting partial immunity? Insights from mathematical modelling
por: Omori, Ryosuke, et al.
Publicado: (2019)

An Apparent Lack of Epidemiologic Association between Hepatitis C Virus Knowledge and the Prevalence of Hepatitis C Infection in a National Survey in Egypt
por: Chemaitelly, Hiam, et al.
Publicado: (2013)

Characterizing herpes simplex virus type 1 and type 2 seroprevalence declines and epidemiological association in the United States
por: Chemaitelly, Hiam, et al.
Publicado: (2019)

Seriously misleading results using inverse of Freeman‐Tukey double arcsine transformation in meta‐analysis of single proportions
por: Schwarzer, Guido, et al.
Publicado: (2019)

Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination
por: Butt, Adeel A., et al.
Publicado: (2021)

History of primary-series and booster vaccination and protection against Omicron reinfection
por: Chemaitelly, Hiam, et al.
Publicado: (2023)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b32ckant33kganph9agb7arfdq